Retrospective Analyses of TrakStar Database
Part of paid clinical trials in Malvern, Pennsylvania.
- Sponsor
- Neuronetics
- Study ID
- NCT06917339
- Status
- Recruiting
Conditions
- Anxiety Depression
- Depression
- Obsessive-Compulsive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - 120 Years
- Healthy Volunteers
- Not accepted
Interventions
- NeuroStar Advanced TMS Therapy System — DEVICEnon-invasive brain stimulation device
Study Details
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
Key Dates
- Start date
- Feb 25, 2025
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2035
- Completion
- Dec 31, 2035
Study Design
- Enrollment
- 156,000 participants (estimated)
Arms
- Arm: Patients treated with NeuroStar TMS
Primary Outcome Measure
Change in clinical assessment score from baseline to post-treatment [ Time Frame: 8 weeks ]
Central Contacts
- Neha Goyal763-528-1599
- Eleanor Cole, PhD415-724-7960
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Neuronetics | Malvern | Pennsylvania | 19355 | Eleanor Cole |
Find similar trials in Malvern, PA
By condition
By specialty
By research site
Related Studies
- Evaluation of the PACE/PACENET BHL Clinical ProgramRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Locating Biomarkers in OCD Through Behavioral TasksNot Yet Recruiting · Baylor College of Medicine · Pittsburgh, Pennsylvania
- Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITENot Yet Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- SEEG-Guided DBS for OCDRecruiting · Casey H. Halpern, M.D. · Stanford, California